US Patent Issued to DANA-FARBER CANCER INSTITUTE on March 25 for "Compositions and methods for transient gene therapy with enhanced stability" (Massachusetts Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,560, issued on March 25, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston).

"Compositions and methods for transient gene therapy with enhanced stability" was invented by Michael Goldberg (Brookline, Mass.) and Ellese Carmona (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides circularized RNA and methods of making and using same."

The patent was filed on April 8, 2021, under Application No. 17/225,823.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l...